未知生产厂商
EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.
EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.
Studies indicate that EHT899 may induce a secondary immune response against the virus, at the same time reducing the undesirable response associated with HBV infection. Oral intake of viral protein could, in some formulations, induce immunological suppression in chronic carriers.
Investigated for use/treatment in hepatitis (viral, B).
